D2-Like Dopamine Receptor Neurons
Introduction
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">D2-Like Dopamine Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Dopamine Receptor Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Striatum, VTA, PFC, Nucleus Accumbens</td>
</tr>
<tr>
<td class="label">Receptor Type</td>
<td>D2 (DRD2), D3 (DRD3), D4 (DRD4)</td>
</tr>
<tr>
<td class="label">Signaling</td>
<td>Gi-coupled, inhibitory</td>
</tr>
<tr>
<td class="label">Neurotransmitter</td>
<td>GABA (striatal), Dopamine (modulatory)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Brain Region</td>
</tr>
<tr>
<td class="label">DRD2</td>
<td>Striatum</td>
</tr>
<tr>
<td class="label">DRD3</td>
<td>Limbic system</td>
</tr>
<tr>
<td class="label">DRD4</td>
<td>Cortex, hippocampus</td>
</tr>
</table>
...D2-Like Dopamine Receptor Neurons
Introduction
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">D2-Like Dopamine Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Dopamine Receptor Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Striatum, VTA, PFC, Nucleus Accumbens</td>
</tr>
<tr>
<td class="label">Receptor Type</td>
<td>D2 (DRD2), D3 (DRD3), D4 (DRD4)</td>
</tr>
<tr>
<td class="label">Signaling</td>
<td>Gi-coupled, inhibitory</td>
</tr>
<tr>
<td class="label">Neurotransmitter</td>
<td>GABA (striatal), Dopamine (modulatory)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Brain Region</td>
</tr>
<tr>
<td class="label">DRD2</td>
<td>Striatum</td>
</tr>
<tr>
<td class="label">DRD3</td>
<td>Limbic system</td>
</tr>
<tr>
<td class="label">DRD4</td>
<td>Cortex, hippocampus</td>
</tr>
</table>
D2-like dopamine receptor neurons express inhibitory dopamine receptors (DRD2, DRD3, DRD4) that mediate motor control, reward processing, and cognitive functions. These neurons are critically involved in Parkinson's disease (PD), Huntington's disease (HD), schizophrenia, and addiction. D2 receptor dysfunction is a hallmark of dopaminergic neurodegeneration[@beaulieu2011].
Overview
Mermaid diagram (expand to render)
Multi-Taxonomy Classification
Taxonomy Database Cross-References
External Database Links
- [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
- [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [Human Cell Atlas](https://www.humancellatlas.org/)
Molecular Properties
Receptor Structure and Signaling
D2-like receptors share common structural features[@missale1998]:
- Family: D2, D3, D4 dopamine receptors
- G protein: Gi/o
- Second messengers: Decreased cAMP, hyperpolarization
- Ion channels: Activation of GIRK channels (Kir3.x)
- Cellular effects: Inhibition of adenylate cyclase, reduced neuronal excitability
Receptor Distribution
Molecular Markers
- Receptor proteins: DRD2, DRD3, DRD4
- Effector proteins: DARPP-32, RGS9, β-arrestin
- Channel proteins: GIRK2 (KCNJ6), GIRK3 (KCNJ9)
- Enzymes: Adenylate cyclase 5 (ADCY5), phosphodiesterases
Normal Function
Motor Control
D2-expressing neurons in the striatum form the indirect pathway[@albin1989]:
Pathway activation: Cortex → striatopallidal neurons → GPi/SNr → thalamus
Movement suppression: Prevents unwanted movements
Action selection: Competes with direct pathway for motor control
Bradykinesia: D2 pathway overactivity contributes to parkinsonian akinesiaReward Processing
D2 neurons encode reward prediction and motivation[@schultz1998]:
- Reward prediction error: Phasic dopamine signals
- Motivation: D2 receptor tone drives reward-seeking
- Reinforcement: D2 activation reinforces behavioral patterns
- Addiction: D2 receptor downregulation in substance abuse
Cognitive Functions
Prefrontal D2 receptors modulate working memory and attention[@goldmanrakic1994]:
- Working memory: D2-mediated prefrontal cortical processing
- Attention: Filtering of irrelevant stimuli
- Decision-making: Risk-reward evaluation
- Cognitive flexibility: Set-shifting abilities
Vulnerability in Neurodegeneration
Parkinson's Disease
D2 receptor neurons are central to PD pathophysiology[@kalia2015]:
D2 autoreceptor loss: Reduced feedback inhibition of dopamine neurons
Striatal D2 upregulation: Compensatory mechanism in early PD
D2/D3 signaling deficits: Impaired motor control
Levodopa-induced dyskinesia: D2 receptor hypersensitivityTherapeutic implications:
- Dopamine agonists (pramipexole, ropinirole) target D2/D3
- D2 partial agonists (aripiprazole) in psychosis
- Deep brain stimulation normalizes D2 pathway activity
Huntington's Disease
D2-expressing neurons are particularly vulnerable in HD[@glass2000]:
Selective striatal degeneration: Indirect pathway neurons degenerate early
D2 receptor loss: Progressive reduction in striatal D2 binding
Motor phenotype: Hyperkinetic movements from D2 pathway dysfunction
Cognitive decline: Prefrontal D2 dysfunctionResearch findings:
- PET imaging shows reduced D2 receptor binding in premanifest HD[@pavese2021]
- Genetic deletion of D2 accelerates HD-like phenotypes in mice
Alzheimer's Disease
D2 receptor dysfunction contributes to AD symptoms[@martorana2014]:
Mesocortical dysfunction: Prefrontal D2 deficits in executive dysfunction
Reward deficits: Anhedonia in AD patients
Behavioral symptoms: Agitation, psychosis from dopaminergic dysfunction
Network disruption: Corticostriatal loop impairmentSchizophrenia
D2 receptor hyperactivity is a key feature of schizophrenia[@howes2012]:
D2 overexpression: Increased D2 receptor density
Signal transduction: Enhanced Gi-coupled inhibition
Therapeutic target: All antipsychotics block D2 receptors
Cognitive deficits: Prefrontal D2 dysfunctionTranscriptomic Profile
Single-cell RNA sequencing has characterized D2 neurons[@gokce2016]:
Marker genes:
- DRD2, DRD3, DRD4 — dopamine receptors
- PENK, PDYN — neuropeptide transmitters
- ARPP21 — cAMP-regulated phosphoprotein
Disease-associated genes:
- DRD2 — schizophrenia risk, Parkinson's response
- DRD3 — Parkinson's dyskinesias, essential tremor
- C9orf72 — ALS/FTD with dopaminergic involvement
- HTT — Huntington's disease
Therapeutic Implications
Pharmacological Targets
- D2 agonists: Pramipexole, ropinirole, rotigotine
- D2 partial agonists: Aripiprazole, cariprazine
- D2 antagonists: Haloperidol, risperidone (antipsychotics)
- D3-selective agents: Selective D3 agonists for Parkinson's
Deep Brain Stimulation
- STN-DBS: Normalizes indirect pathway activity
- GPi-DBS: Reduces D2-mediated output
- Effects on D2 signaling: Modulates receptor sensitivity
Gene Therapy
- AAV-mediated D2 receptor delivery
- CRISPR editing of D2 receptor variants
- RNA targeting of D2 transcript
- D1-Like Dopamine Receptor Neurons
- Striatal Medium Spiny Neurons
- [Parkinson's Disease](/diseases/parkinsons-disease)parkin)
- [Huntington's Disease](/diseases/huntingtons)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- Dopamine Signaling Pathway
- Basal Ganglia Circuitry
Background
The study of D2 Like Dopamine Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
Pathway Diagram
The following diagram shows the key molecular relationships involving D2-Like Dopamine Receptor Neurons discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)